Trial-Results center  
Clinical trial results database Feedback    Home

Related trials

ERICA, 2006 - ranolazine 1000mg + amlodipine vs placebo + amlodipine

RAN080, 2005 - ranolazine 1000mg vs placebo

CARISA 1000mg, 2004 - ranolazine 1000mg vs placebo (on top standard treatment)

MARIZA, 2004 - ranolazine 1000mg vs placebo

See also:

  • All coronary artery disease clinical trials
  • All stable angina clinical trials
  • All clinical trials of anti-anginal drugs
  • All clinical trials of ranolazine 1000mg + amlodipine

    ERICA study, 2006



    Studied treatment ranolazine 1000 mg twice a day for 6 weeks + amlodipine (10 mg/d)
    Control treatment placebo + amlodipine (10 mg/d)


    Patients patients with stable chronic angina already treated with the maximal dose of amlodipine (10mg/d)

    Method and design

    Randomized effectives 281 / 284 (studied vs. control)
    Design Parallel groups
    Blinding double blind
    Follow-up duration 6 weeks
    Number of centre 48
    Geographic area Europe, USA, Canada
    Primary endpoint angina frequency


    No results available for this trial - no clinical endpoint reported


    Trials register # NCT00091429
    Study web site link ,
    • Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.. J Am Coll Cardiol 2006 Aug 1;48:566-75
      Pubmed | Hubmed | Fulltext

    (c) 2004-2010 TrialResults-center - All Rights Reserved

    Tweet this  |  notify a friend